有什么可用于支持帕金森病的疼痛管理:一个范围审查协议
Mark Parkinson1, Cormac Ryan2, Leah Avery2
1Faculty of Health & Life Sciences, Department of Sport, Northumbria University, Exercise & Rehabilitation, Coach Lane Campus, Coach Lane, Newcastle-Upon-Tyne, UK. mark2.parkinson@northumbria.ac.uk.
International journal for equity in health
|November 23, 2023
概括
本范围审查检查了帕金森病疼痛管理的证据,重点关注行为干预和自我管理的专业支持. 它旨在确定有效的策略和当前护理的差距,以改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 疼痛管理 疼痛管理
- 行为科学 行为科学
背景情况:
- 帕金森病经常伴有疼痛,影响生活质量.
- 有效的疼痛管理策略,特别是行为干预,对于患有帕金森病的人来说至关重要.
- 了解当前对自我管理的支持对于优化护理至关重要.
研究的目的:
- 绘制有关帕金森病疼痛管理干预措施的证据.
- 专注于行为干预和专业支持,以自我管理疼痛.
- 识别有效的策略,障碍,推动者和疼痛管理提供缺口.
主要方法:
- 使用Arksey和O'Malley框架进行范围审查,并进行了增强.
- 从2010年1月开始,在多个数据库 (PubMed,SCOPUS,CINAHL,MEDLINE,Web of Science,PsycINFO,ASSIA) 进行了全面的文献搜索.
- 基于COM-B行为变化模型和理论领域框架的定量和定性数据分析.
主要成果:
- 审查将描述可用的疼痛管理支持,干预方向和行为改变组件.
- 将评估已确定的行为干预措施的有效性.
- 将探讨有效疼痛管理的障碍和促进因素.
结论:
- 本综述将全面概述支持帕金森病疼痛管理的证据.
- 这些发现将为"帕金森病中的疼痛"项目提供信息,指导未来的研究和临床实践.
- 该研究旨在改善自我管理支持,并确定加强疼痛护理的优先事项.
相关概念视频
Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278
Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560
Analgesia and Pain Management
632
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
632


